Experimental approaches, such as early intraventricular injection of gene therapy vectors like rAAV-VEGF and rAAV-Ang1 aim to mitigate BBB dysfunction by controlling VEGF-mediated vascular leakage, Left unchecked, increased BBB permeability could elevate the risk of hemorrhagic transformation post-stroke [93]. This evidence concerns the gene VEGFA and Stroke.